Systems Oncology

Systems Oncology

Biotechnology, 3955 Faber Pl Dr, Scottsdale, Arizona, 29405, United States, 11-50 Employees

systemsoncology.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: 14*********

Who is SYSTEMS ONCOLOGY

Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and comba...

Read More

map
  • 3955 Faber Pl Dr, Scottsdale, Arizona, 29405, United States Headquarters: 3955 Faber Pl Dr, Scottsdale, Arizona, 29405, United States
  • 2015 Date Founded: 2015
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 4581

checked-icon Does something look wrong? Fix it. | View contact records from SYSTEMS ONCOLOGY

Systems Oncology Org Chart and Mapping

Employees

Marvin Oketch

Associate Director, Immunobiology

Jeff Kiefer

Senior Vice President, Discovery Research

David Azorsa

Senior Vice President, Bioengineering

Katy Marhenke

Director of Business Development Operations

David Lee

Lab Manager/Sr. Researcher

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Systems Oncology

Answer: Systems Oncology's headquarters are located at 3955 Faber Pl Dr, Scottsdale, Arizona, 29405, United States

Answer: Systems Oncology's phone number is 14*********

Answer: Systems Oncology's official website is https://systemsoncology.com

Answer: Systems Oncology's revenue is $25 Million to $50 Million

Answer: Systems Oncology's SIC: 4581

Answer: Systems Oncology has 11-50 employees

Answer: Systems Oncology is in Biotechnology

Answer: Systems Oncology contact info: Phone number: 14********* Website: https://systemsoncology.com

Answer: Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our Arromer platform is used to digitally engineer and rapidly produce self-delivering therapeutics which target specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of products in oncology, yet our multimodal RNA platform can be harnessed to transform outcomes for any complex polygenic disease.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access